Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021–June 2022

BACKGROUND: We assessed the association between antibody concentration ≤5 days of symptom onset and COVID-19 illness among patients enrolled in a test-negative study. METHODS: From October 2021–June 2022, study sites in seven states enrolled and tested respiratory specimens from patients of all ages...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumner, Kelsey M., Yadav, Ruchi, Noble, Emma K., Sandford, Ryan, Joshi, Devyani, Tartof, Sara Y., Wernli, Karen J., Martin, Emily T, Gaglani, Manjusha, Zimmerman, Richard K., Talbot, H. Keipp, Grijalva, Carlos G., Chung, Jessie R., Rogier, Eric, Coughlin, Melissa M., Flannery, Brendan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543239/
https://www.ncbi.nlm.nih.gov/pubmed/37790578
http://dx.doi.org/10.1101/2023.09.21.23295919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543239/
https://www.ncbi.nlm.nih.gov/pubmed/37790578
http://dx.doi.org/10.1101/2023.09.21.23295919

Ejemplares similares